Amanda Psyrri, MD-PhD is Professor of Medical Oncology at National Kapodistrian University of Athens and Chair of the Department of Medicine at Attikon University Hospital. She achieved her MD from the Medical School at the University of Patras (Greece) in 1993.  From 1996-2002, Prof. Psyrri did her residency in Internal Medicine, followed by a Medical Oncology/Hematology Fellowship at Yale University School of Medicine & Yale Cancer Center (New Haven/CT) in the United States of America (USA). She is Board-Certified in Internal Medicine and Medical Oncology in the USA and in Greece. She joined the Faculty of Medicine at the Section of Medical Oncology at Yale as an Instructor in 2002 and was promoted to Assistant Professor in 2003. At Yale, Prof. Psyrri led the clinical and translational research program in head and neck malignancies focusing on HPV-induced carcinogenesis and biomarkers. In 2007, Prof. Psyrri received her Ph.D. Degree from the National Kapodistrian University of Athens and joined the Faculty of Medicine in 2009. In 2012, Professor Psyrri was appointed Head of Medical Oncology at Attikon University Hospital. Prof. Psyrri is currently in charge of research, teaching, and patient care in medical oncology and head and neck malignancies at the Section of Oncology of Attikon University Hospital. She also leads a Molecular Oncology laboratory. Her current research projects are focused on combined immunotherapy to treat recurrent/metastatic HNSCC and identify predictors for response to PD1 inhibitors in HNSCC. She is on the steering committee of several industry-sponsored and PI of investigator-initiated clinical trials of immunotherapy in HNSCC.  Between 2007 and 2015, Prof Psyrri was the Translational Research Chair of the European Organization for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group. She is also the Chair of Head and Neck Cancer Group of the Hellenic Cooperative Oncology Group (HeCOG), a founding member and European Representative of the Head and Neck Cancer Intergroup (HNCIG) and Secretary of the HNCIG. From 2017-2021 Prof. Psyrri was the scientific director of HECOG. Professor Psyrri was elected chair of Nomination Committee at ESMO for the period 2021-2023. Prof. Psyrri an active member of the educational program within ESMO. She is faculty coordinator of the ESMO Faculty for Head and Neck Cancer. Prof. Psyrri has been a member of the Scientific Committee of Head & Neck cancer track at several ESMO Congresses. In 2015, she was ESMO Chair at the International Conference on Innovative Approaches in Head and Neck Oncology (ICHNO) in Nice, France. She was co-Chair of the Scientific Committee Track Head & Neck Cancer for ECCO 2015 in Vienna, Chair of the Scientific Committee Track Head & Neck Cancer of ESMO 2016 and ESMO 2018 congresses, and co-chair of ESMO ASIA 2020 Congress. She currently serves as the Chair of the ESMO National Societies Committee and she is member of the ESMO Council since 2021. Professor Psyrri has been invited Faculty Speaker at numerous international oncology conferences including, ASCO Annual meetings, ESMO Congresses, American Head &Neck Society Meetings, American Society of Radiation Oncology Meeting, HPV Eurogin Conferences.  She is a member of AACR (American Association for Cancer Research), ASCO (American Society of Clinical Oncology), EORTC, and Society of Immunotherapy of Cancer (SITC). She is a founding member of Women for Oncology (W4O)-Greece and a member of SITC’s Women in Cancer Immunotherapy Network. Prof. Psyrri has authored numerous peer-reviewed manuscripts, and book chapters served as the associate editor of ‘Frontiers in Oncology” and became Editor of “Oral Oncology” in 2026. Also, she acts as Associate Editor for ‘Cancers,’ and she is in the Editorial Board of Annals of Oncology and Associate Editor of the “ESMO OPEN”.